What are the treatment options for conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Conjunctivitis

Immediate Triage: Red Flags Requiring Urgent Ophthalmology Referral

If any of the following are present, refer immediately to ophthalmology before initiating treatment: 1, 2

  • Visual loss
  • Moderate to severe pain (suggests keratitis, uveitis, or acute angle-closure glaucoma)
  • Severe purulent discharge (consider gonococcal infection)
  • Corneal involvement (fluorescein staining showing epithelial defects)
  • Conjunctival scarring
  • Lack of response after 3-4 days of appropriate therapy
  • Recurrent episodes
  • History of HSV eye disease
  • Immunocompromised state
  • Neonatal conjunctivitis (mandatory hospitalization and systemic treatment) 1, 2

Treatment Algorithm by Etiology

Bacterial Conjunctivitis

For mild to moderate bacterial conjunctivitis, prescribe a 5-7 day course of broad-spectrum topical antibiotic (e.g., moxifloxacin 0.5% three times daily). 1, 2, 3 This accelerates clinical and microbiological remission in days 2-5, reduces transmissibility, and allows earlier return to school/work. 3

Clinical features suggesting bacterial etiology: 4, 5

  • Mucopurulent discharge with eyelids matted shut on waking
  • Lack of itching
  • No history of previous conjunctivitis
  • More common in children

Antibiotic selection: 2, 3

  • First-line: Topical fluoroquinolones (moxifloxacin, gatifloxacin, levofloxacin, ciprofloxacin, ofloxacin) provide superior coverage against Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae 2, 3, 6
  • Fourth-generation fluoroquinolones (moxifloxacin, gatifloxacin) have better gram-positive coverage, including some MRSA strains 3
  • Alternative options: Polymyxin B/trimethoprim, erythromycin, gentamicin, or tobramycin 2, 3
  • No evidence demonstrates superiority of any specific agent for uncomplicated cases, so choose based on cost and convenience 2, 3

Special circumstances requiring systemic antibiotics: 1, 2

  • Gonococcal conjunctivitis: Ceftriaxone 250 mg IM single dose PLUS azithromycin 1 g oral single dose; requires daily monitoring until resolution and hospitalization may be necessary 1, 2, 3
  • Chlamydial conjunctivitis: Azithromycin 1 g oral single dose OR doxycycline 100 mg oral twice daily for 7 days; topical therapy alone is insufficient 1, 2, 3
  • MRSA conjunctivitis: May require compounded topical vancomycin, as MRSA is resistant to most commercially available topical antibiotics 2, 3
  • Contact lens wearers: Use fluoroquinolones due to higher risk of Pseudomonas infection 3

Critical follow-up: Advise patients to return if no improvement after 3-4 days of treatment. 1, 2, 3

Viral Conjunctivitis

Viral conjunctivitis requires supportive care only—do NOT prescribe antibiotics. 1, 2, 4 Most cases are self-limited and resolve without treatment.

Clinical features suggesting viral etiology: 1, 4, 5

  • Watery discharge
  • Preauricular lymphadenopathy
  • Concurrent upper respiratory infection
  • Follicular reaction in inferior fornix
  • More common in adults

Supportive treatment: 1, 2

  • Refrigerated preservative-free artificial tears 4 times daily (dilutes viral particles and inflammatory mediators)
  • Cold compresses for comfort
  • Topical antihistamines for symptomatic relief of itching (NOT for viral eradication)

Exception—HSV conjunctivitis: 2

  • Topical ganciclovir 0.15% gel OR topical trifluridine 1% solution 2
  • Oral antivirals: Acyclovir, valacyclovir, or famciclovir 2
  • NEVER use topical corticosteroids in HSV conjunctivitis without antiviral coverage—they potentiate infection 1, 2

Infection control: 1, 2

  • Strict handwashing with soap and water
  • Avoid close contact for 7-14 days from symptom onset
  • Discard multiple-dose eyedrop containers to prevent cross-contamination
  • Disinfect surfaces with EPA-registered hospital disinfectant or 1:10 dilution of household bleach

Allergic Conjunctivitis

For allergic conjunctivitis, prescribe topical antihistamines with mast cell-stabilizing properties as first-line treatment. 1, 2 These are the treatment of choice for allergic conjunctivitis.

Clinical features suggesting allergic etiology: 4, 5, 7

  • Itching (most consistent sign)
  • Watery discharge
  • Concurrent allergic rhinitis or asthma
  • Allergen exposure history

Treatment algorithm: 1, 2

  1. First-line: Topical antihistamines with mast cell-stabilizing activity (e.g., olopatadine, ketotifen) 1, 2
  2. Adjunctive measures: Cold compresses, refrigerated preservative-free artificial tears, wearing sunglasses as allergen barrier 1, 2
  3. Persistent/recurrent cases: Add mast cell stabilizers 1
  4. Severe cases: Brief 1-2 week course of low side-effect profile topical corticosteroids (e.g., loteprednol); monitor intraocular pressure and for cataract formation 1, 2

Environmental modifications: Identify and avoid allergen triggers. 1

Critical Pitfalls to Avoid

  • Never use topical corticosteroids indiscriminately—they prolong adenoviral infections, worsen HSV infections, and can induce toxicity 1, 2
  • Never prescribe antibiotics for viral conjunctivitis—this promotes resistance and provides no benefit 2, 3
  • Never use topical therapy alone for gonococcal or chlamydial conjunctivitis—systemic antibiotics are mandatory 1, 2, 3
  • Always treat sexual contacts concurrently in sexually transmitted conjunctivitis 1
  • Always consider sexual abuse in children with gonococcal or chlamydial conjunctivitis 1, 2
  • Never allow contact lens wear until complete resolution of conjunctivitis 1

Special Populations

Neonates: 1, 2

  • Gonococcal: Ceftriaxone 25-50 mg/kg IV or IM single dose; hospitalization mandatory
  • Chlamydial: Erythromycin base or ethylsuccinate 50 mg/kg/day oral divided in 4 doses for 14 days; >50% have infection at other sites requiring systemic treatment

Pregnant women: 2

  • Avoid doxycycline and quinolones
  • Use erythromycin or azithromycin for chlamydial coverage

Contact lens wearers: 3

  • Discontinue lens use until complete resolution
  • Use fluoroquinolones due to Pseudomonas risk

References

Guideline

Treatment of Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Conjunctivitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Conjunctivitis: Diagnosis and Management.

American family physician, 2024

Research

Conjunctivitis.

American family physician, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.